Pharmacokinetics of antisense analogues in the central nervous system

Neurochemistry International

Volumn 31, Issue 3, 1997, Pages 413-423

  Szklarczyk, Arkadiusz ^a   Kaczmarek, Leszek ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ENDONUCLEASE; EXONUCLEASE; PHOSPHODIESTER; PHOSPHOROTHIOIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MALE; MOLECULAR WEIGHT; NERVOUS TISSUE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RADIOACTIVITY; RAT; TISSUE DISTRIBUTION;

ANIMALS; CENTRAL NERVOUS SYSTEM; HIPPOCAMPUS; NEURONS; OLIGONUCLEOTIDES, ANTISENSE; THIONUCLEOTIDES; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0030792460     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00111-8     Document Type: Article

References (43)

1. Agrawal, S., Temsamani, J. and Tang, J. Y. (1991) Pharmacokinetics, biodistribution and stability of oligodeoxynucleotide phosphorothioates in mice. Proc. Natl. Acad. Sci. U.S.A. 88, 7595-7599.
2. Akhtar, S. and Juliano, R. L. (1992) Cellular uptake and intracellular fate of antisense oligonucleotides. Trends Cell. Biol. 2, 139-144.
3. Baserga, R. and Denhardt, D. T. (1992) Antisense strategies. Ann. NY Acad. Sci. 660.
4. Campbell, J, M., Bacon, T. A. and Wickstrom, E. (1990) Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid. J. Biochem. Biophys. Meth. 20, 259-267.
5. Chiasson, B, J., Hooper, M. L., Murphy, P. R. and Robertson, H. A. (1992) Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 227, 451-453.
6. Cook P. D. (1993) Medicinal chemistry strategies for antisense research. In Antisense Research and Applications (Crooke S. T. and Lebleu B., Eds), pp. 149-189. CRC Press, Ann Arbor.
7. Crook, R. M. (1991) In vitro toxicology and pharmacokinetics of antisense oligonucleotides. Anti-Cancer Drug Design 6, 609-646.
8. Dragunow, M., Tse, C., Glass, M. and Lawlor, P. (1994) c-fos antisense reduces expression of Krox 24 in rat caudate and neocortex. Cell. Mol. Neurobiol. 14, 395-405.
9. Eckstein, F. (1985) Nucleoside phosphorothioates. Annu. Rev. Biochem. 54, 367-402.
10. Ehrlich, G., Patinkin, D., Ginzberg, D., Zakut, H., Eckstein, F. and Soreq, H. (1994) Use of phosphorothioated antisense oligonucleotides for sequence-dependent modulation of hematopoesis in culture. Antisense Res. Devl. 4, 173-183.
11. Gao, W. I., Han, F. S., Storm, C., Egan, W. and Cheng, Y. C. (1992) Phosphorothioate oligonucleotides are inhibitors of human DNA polimerases and RNAse H: implications for antisense technology. Mol. Pharmacol. 41, 223-229.
12. Ghosh, M. K., Gllosh, K. and Cohen, J. S. (1993) Phosphorothioate-phosphodiester oligonucleotide copolimers: assessment for antisense application. Anti-Cancer Drug Design 8, 15-39.
13. 2+. Biochem. Biophys. Res. Commun. 181, 915-920.
14. Gillardon, F., Beck, H., Uhlmann, E., Herdegen, T., Sandkuhler, J., Peyman, A. and Zimmerman, M. (1994) Inhibition of c-fos protein expression in rat spinal cord by antisense oligodeoxynucleotide superfusion. Eur. J. Neurosci. 6, 880-884.
15. Giuffrida, A., Cox, D. and Mathias, A. P. (1975) RNA polymerase activity in various classes of nuclei from different regions of rat brain during postnatal development. J. Neurochem. 24, 749-755.
16. Haugland R. P. and Larison K. D. (1992) Handbook of Fluorescent Probes and Research Chemicals, Molecular Probes Inc., U.S.A.
17. Heilig, M., Engel, J. A. and Soderpalm, B. (1993) c-Fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine. Eur. J. Pharmacol. 236, 339-340.
18. Hélène, C. and Toulmé, J. J. (1990) Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim. Biophys. Acta 1049, 99-125.
19. Hoke, G. D., Draper, K., Freier, S. M., Gonzalez, C., Driver, V. B., Zounes, M. C. and Ecker, D. J. (1991) Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection, Nucl. Acids Res. 19, 5743-5748.
20. Iwanaga, T. and Ferriola, P. C. (1993) Cellular uptake of phosphorothioate oligodeoxynucleotides is negatively affected by cell density in a transformed rat tracheal epithelial cell line: implication for antisense approaches. Biochem. Biophys. Res. Commun. 191, 1152-1157.
21. Jirikowski, G. F., Sanna, P. P., Maciejewski-Lenoir, D. and Bloom, F. (1993) Reversal of diabetes insipidus in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA. Science 255, 996-998.
22. Johnson, S. A., Morgan, D. G. and Finch, C. E. (1986) Extensive post-mortem stability of RNA from rat and human brain. J. Neurosci. Res. 16, 267-280.
23. Krieg, A. M., Gmelig-Meyling, F., Gourley, M. F., Kisch, W. J., Chrisey, L. A. and Steinberg, A. D. (1991) Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible. Antisense Res. Devl. 1, 161-171.
24. Lacks, S. A. (1981) Deoxyribonuclease I in mammalian tissues. J. Biol. Chem. 256, 2644-2648.
25. Liu, P. K., Salminen, A., He, Y. Y., Jiang, M. H., Xue, J. J., Liu, J. S., Hsu, C. Y. and Hsu, C. Y. (1994) Suppression of ischemia-induced c-fos expression and AP-1 activity by an antisense oligonucleotide to c-fos mRNA. Ann. Neurol. 36, 566-576.
26. McCarthy, M. M., Brooks, P. J., Pfaus, J, G., Brown, H. E., Flanagan, L. M., Schwartz-Giblin, S. and Pfaff, D. W. (1993) Antisense oligodeoxynucleotides in behavioral neuroscience. Neuroprotocols: A Companion to Meth. Neurosci. 2, 67-74.
27. Neckers L. M. (1993) Cellular internalization of oligodeoxynucleotides. In Antisense Research and Applications (Crooke S. T. and Lebleu B., Eds.), pp. 452-459. CRC Press, Ann Arbor..
28. Ogawa, S., Olazabal, U. E., Parhar, I. S. and Pfaff, D. W. (1994) Effects of intrahypothalamic administration of antisense DNA for progesterone receptor mRNA on reproductive behavior and progesterone receptor immunoreactivity in female rat. J. Neurosci. 14, 1766-1774.
29. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Co-ordinates, Academic Press, New York.
30. Pollio, G., Xue, P., Zanisi, M., Nicolin, A. and Maggi, A. (1993) Antisense oligonucleotide blocks progesterone-induced lordosis behaviour in ovarectomised rats. Mol. Brain. Res. 19, 135-139.
31. Robertson, G. S., Tetzlaff, W., Bedard, A., St-Jean, M. and Wigle, N. (1995) c-Fos mediates antipsychotic-induced neurotensin gene expression in the rodent striatum. Neuroscience 67, 325-344.
32. Sambrook J., Fritsch E. F. and Maniatis T. (1989) Molecular Cloning: A Laboratory Manual, pp. 11.23-11.28. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
33. Smidt, P. C., Doan, T., Falco, S. and Berkel, T. J. C. (1991) Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution. Nucl. Acids Res. 19, 4695-4700.
34. Sommer, W., Bjelke, B., Ganten, D. and Fuxe, K. (1993) Antisense oligonucleotide to c-fos induces ipsilateral rotational behavior to d-amphetamine. Neuroreport 5, 277-280.
35. Standifer, K. M., Jenab, S., Su, W., Chien, C. C., Pan, Y. X., Inturrisi, C. E. and Pasternak, W. (1995) Antisense oligodeoxynucleotides to the cloned d receptor DOR-1: uptake, stability, and regulation of gene expression. J. Neurochem. 65, 1981-1987.
36. Stec, W. J., Zon, G., Egan, W. and Stec, B. (1984) Automated solid-phase synthesis, separation, and stereochemistry of phosphorothioate analogs of oligodeoxyribonucleotides. J. Am. Chem. Soc. 106, 6077-6079.
37. Stein, C. A., Subasinghe, C., Shinozuka, K. and Cohen, J. S. (1988) Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucl. Acids Res. 16, 3209-3291.
38. Stein, C. A., Tonkinson, J. L., Zhang, L. M., Yakubow, L., Gervasoni, J., Taub, R. and Rotenberg, S. A. (1993) Dynamics of the internalization of phosphodiester oligodeoxynucleotides in L60 cells. Biochemistry 32, 4855-4861.
39. Szklarczyk, A. and Kaczmarek, L. (1995) Antisense oligodeoxyribonucleotides: stability and distribution after intracerebral infusion into rat brain. J. Neurosci. Meth. 60, 181-187.
40. Tischmeyer, W., Grimm, R., Schicknick, H., Brysch, W. and Schlingensiepen, K. H. (1994) Sequence specific impairment of learning by c-jun antisense oligonucleotides. NeuroReport 5, 1501-1504.
41. Wahlestedt, C. (1994) Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol. Sci. 15, 42-46.
42. Whitesell, L., Geselowitz, D., Chavany, C., Fahmy, B., Walbridge, S., Alger, J. R. and Neckers, L. M. (1993) Stability, clearance and disposition of intraventriculary administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 90, 4665-4669.
43. Yee, F., Ericson, H., Reis, D. J. and Wahlstedt, C. (1994) Cellular uptake of intracerebroventricularly administered biotin-or digoxigenin labeled antisense oligodeoxynucleotides in the rat. Cell. Mol. Neurobiol. 14, 475-487.